KRS Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $722K | Sell |
1,622
-115
| -7% | -$51.2K | 0.48% | 44 |
|
|
2025
Q1 | $842K | Sell |
1,737
-15
| -0.9% | -$7.27K | 0.67% | 31 |
|
|
2024
Q4 | $706K | Hold |
1,752
| – | – | 0.5% | 42 |
|
|
2024
Q3 | $815K | Sell |
1,752
-15
| -0.8% | -$6.98K | 0.59% | 34 |
|
|
2024
Q2 | $828K | Hold |
1,767
| – | – | 0.62% | 33 |
|
|
2024
Q1 | $739K | Hold |
1,767
| – | – | 0.6% | 38 |
|
|
2023
Q4 | $719K | Hold |
1,767
| – | – | 0.67% | 39 |
|
|
2023
Q3 | $614K | Hold |
1,767
| – | – | 0.65% | 43 |
|
|
2023
Q2 | $622K | Sell |
1,767
-25
| -1% | -$8.8K | 0.62% | 44 |
|
|
2023
Q1 | $565K | Buy |
1,792
+200
| +13% | +$63K | 0.64% | 44 |
|
|
2022
Q4 | $460K | Buy |
1,592
+200
| +14% | +$57.8K | 0.63% | 50 |
|
|
2022
Q3 | $403K | Buy |
1,392
+125
| +10% | +$36.2K | 0.56% | 55 |
|
|
2022
Q2 | $357K | Hold |
1,267
| – | – | 0.51% | 67 |
|
|
2022
Q1 | $330K | Buy |
1,267
+150
| +13% | +$39.1K | 0.36% | 82 |
|
|
2021
Q4 | $245K | Buy |
+1,117
| New | +$245K | 0.21% | 104 |
|